Skip to main content

Table 2 Local tumor response at 3 months and 6 months after treatment

From: CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study

Treatment

3 months

6 months

CR

PR

SD

PD

OR

DC

CR

PR

SD

PD

OR

DC

DEB-TACE (n = 24)

6 (25.0%)

14 (58.3%)

2 (8.3%)

2 (8.3%)

20 (83.3%)

22 (91.7%)

5 (20.8%)

10 (41.7%)

5 (20.8%)

4 (16.7%)

15 (62.5%)

20 (83.3%)

cTACE (n = 30)

1 (3.3%)

12 (40.0%)

7 (23.3%)

10 (33.3%)

13 (43.3%)

20 (66.7%)

0

9 (30.0%)

8 (26.7%)

13 (43.3%)

9 (30.0%)

17 (56.7%)

χ2 value

5.548

1.795

2.160

4.821

8.977

4.821

6.888

0.796

0.248

4.396

5.704

4.396

p value

0.019

0.180

0.142

0.028

0.003

0.028

0.009

0.372

0.618

0.036

0.017

0.036

  1. CR complete response, PR partial response, SD stable disease, PD progressive disease, OR objective response, DC disease control